By comparison, a 98% overall response rate and an 83% stringent complete ... and no prior exposure to B-cell maturation antigen (BCMA)-targeted therapy. In the current study, patients receiving ...
Oct. 11, 2024 — Researchers have developed a new method to recreate a robust and functional human immune system in mice using mononuclear cells from the cord blood. This new kind of mice ...
Oct. 9, 2024 — Researchers have developed a groundbreaking cell culture platform that enables the formation of two distinct but interconnected vascular networks. Their breakthrough holds ...